Ayala Pharmaceuticals, Inc. Contracts & Agreements

31 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
Ayala Pharmaceuticals, Inc.
Biotechnology
2023
Agreement and Plan of Merger, dated as of October 18, 2022, by and among Advaxis, Inc., Doe Merger Sub, Inc., and Ayala Pharmaceuticals, Inc
Merger Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
DE
2022
Voting and Support Agreement, dated as of October 18, 2022, by and between Advaxis, Inc. and Israel Biotech Fund I, L.P
Voting Agreements
Ayala Pharmaceuticals, Inc.
2022
Voting and Support Agreement, dated as of October 18, 2022, by and between Advaxis, Inc. and aMoon Growth Fund Limited Partnership
Voting Agreements
Ayala Pharmaceuticals, Inc.
2022
Letter Agreement, dated as of October 18, 2022, by and between Ayala-Oncology Israel Ltd. and Roni Mamluk
Ayala Pharmaceuticals, Inc.
Biotechnology
2022
Letter Agreement, dated as of October 18, 2022, by and between Ayala-Oncology Israel Ltd. and Yossi Maimon
Ayala Pharmaceuticals, Inc.
Biotechnology
2022
Letter Agreement, dated as of October 18, 2022, by and between Ayala Pharmaceuticals, Inc. and Gary Gordon
Ayala Pharmaceuticals, Inc.
2022
Amendment No. 2 to Amended and Restated Investors Rights Agreement, dated as of June 4, 2021
Investor Rights Agreements
Ayala Pharmaceuticals, Inc.
2022
Form of Underwriting Agreement
Underwriting Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
2022
Form of Common Stock Warrant
Warrant Agreements
Ayala Pharmaceuticals, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Ayala Pharmaceuticals, Inc.
2022
Description of Securities
Ayala Pharmaceuticals, Inc.
Biotechnology
2022
Description of Securities
Ayala Pharmaceuticals, Inc.
2021
Form of Common Warrant
Warrant Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated February 19, 2021, by and among Ayala Pharmaceuticals, Inc. and the Investors named therein
Purchase Agreements
Ayala Pharmaceuticals, Inc.
2021
Amended and Restated Investors Rights Agreement, as amended
Investor Rights Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
DE
2020
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Ayala Pharmaceuticals, Inc.
2020
Amended 2017 Stock Incentive Plan and form of agreements thereunder
Bonus & Incentive Agreements
Ayala Pharmaceuticals, Inc.
2020
Non-Employee Director Compensation Program
Compensation Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
2020
Form of Indemnification Agreement for Directors and Officers
Indemnification Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
DE
2020
Employment Agreement, dated July 24, 2019, between the Registrant and Gary Gordon M.D., Ph.D., as amended
Employment Agreements
Ayala Pharmaceuticals, Inc.
2020
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company, as amended
License Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
DE
2020
Form of Underwriting Agreement
Underwriting Agreements
Ayala Pharmaceuticals, Inc.
2020
Amended and Restated Investors Rights Agreement
Investor Rights Agreements
Ayala Pharmaceuticals, Inc.
2020
Lease Agreement, dated January 24, 2019, between Ayala-Oncology Israel Ltd. and Ogen Real Estate Maniv Ltd
Lease Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
2020
Employment Agreement, dated December 26, 2017, between Ayala-Oncology Israel Ltd. and Roni Mamluk, Ph.D., as amended
Employment Agreements
Ayala Pharmaceuticals, Inc.
2020
Employment Agreement, dated March 15, 2019, between Ayala-Oncology Israel Ltd. and Yossi Maimon, CPA, M.B.A., as amended
Employment Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
2020
Employment Agreement, dated July 24, 2019, between the Registrant and Gary Gordon M.D., Ph.D
Employment Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
2020
License Agreement, dated November 29, 2017, between the Registrant and Bristol-Myers Squibb Company
License Agreements
Ayala Pharmaceuticals, Inc.
Biotechnology
DE
2020
Evaluation, Option and License Agreement, dated December 19, 2018, between the Registrant and Novartis International Pharmaceutical Limited
License Agreements
Ayala Pharmaceuticals, Inc.
2020